SHP-1 Regulates CD8+T Cell Effector Function but Plays a Subtle Role with SHP-2 in T Cell Exhaustion Due to a Stage-Specific Nonredundant Functional Relay

An Integrated Multi-Omics Analysis Identifying Immune Subtypes of Pancreatic Cancer

MHC class II regulation of CD8+T cell tolerance and implications in autoimmunity and cancer immunotherapy

Themis suppresses the effector function of CD8<SUP>+</SUP> T cells in acute viral infection

Integration of Protein Nanocage with CpG Motifs: A Virus-Mimicked Core-Shell Nanostructure to Ignite Antitumor Immunity

Themis is indispensable for IL-2 and IL-15 signaling in T cells

IFN-gamma-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella

Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemia

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy.

Monoubiquitination of p120-catenin is essential for TGF beta-induced epithelial-mesenchymal transition and tumor metastasis

CCL4 enhances blinatumomab therapy in a human B-ALL xenograft mouse model

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies (vol 33, pg 2315, 2019)

Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies

Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy

Synthetic lethality of combined AT-101 with idarubicin in acute myeloid leukemia via blockade of DNA repair and activation of intrinsic apoptotic pathway

Patient's T Cell Functionality Determines Blinatumomab-Mediated Killing of B-ALL Leukemia Cells

Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia